Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gosselin

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Seminars in Thrombosis and Hemostasis|March 7, 2017
Factor Activity Assays for Monitoring Extended Half-Life FVIII and Factor IX Replacement TherapiesSteve Kitchen, Stefan Tiefenbacher, Robert Gosselin
Seminars in Thrombosis and Hemostasis|June 20, 2019
Current and Emerging Direct Oral Anticoagulants: State-of-the-ArtGiuseppe Lippi, Robert Gosselin, Emmanuel J Favaloro
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 7, 2013
Hypercoagulability among pediatric patients with diabetic ketoacidosis: the clot thickensJames P Marcin, Robert Gosselin, Paul Holland
Clinical Toxicology (Philadelphia, Pa.)|May 21, 2005
Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomationChristopher Camilleri, Steven Offerman, Robert Gosselin, et al.
American Journal of Clinical Pathology|January 18, 2014
Performance of various laboratory assays in the measurement of dabigatran in patients receiving therapeutic doses: a prospective study based on peak and trough plasma levelsRobert Gosselin, Emily Hawes, Stephan Moll, et al.
Hamostaseologie|July 6, 2017
Clinical pearls: Laboratory assessments of direct oral anticoagulants (DOACS)Robert C Gosselin, Robert Gosselin, Jonathan Douxfils, et al.
American Journal of Clinical Pathology|December 29, 2012
The effect of dabigatran on select specialty coagulation assaysDorothy M Adcock, Robert Gosselin, Steve Kitchen, et al.
Clinical Chemistry and Laboratory Medicine|May 4, 2018
Recent initiatives in harmonization of hemostasis practiceEmmanuel J Favaloro, Robert Gosselin, John Olson, et al.
Journal of Thrombosis and Thrombolysis|March 23, 2013
Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhageJennifer L Aron, Robert Gosselin, Stephan Moll, et al.
European Journal of Radiology|October 8, 2008
MR imaging changes in the trochanteric area of asymptomatic individuals: a potential for misdiagnosis of pain in the trochanteric regionMichel De Maeseneer, Robert Gosselin, Fillip De Ridder, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Seminars in Thrombosis and Hemostasis|March 7, 2017
Factor Activity Assays for Monitoring Extended Half-Life FVIII and Factor IX Replacement TherapiesSteve Kitchen, Stefan Tiefenbacher, Robert Gosselin
Seminars in Thrombosis and Hemostasis|June 20, 2019
Current and Emerging Direct Oral Anticoagulants: State-of-the-ArtGiuseppe Lippi, Robert Gosselin, Emmanuel J Favaloro
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 7, 2013
Hypercoagulability among pediatric patients with diabetic ketoacidosis: the clot thickensJames P Marcin, Robert Gosselin, Paul Holland
Clinical Toxicology (Philadelphia, Pa.)|May 21, 2005
Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomationChristopher Camilleri, Steven Offerman, Robert Gosselin, et al.
American Journal of Clinical Pathology|January 18, 2014
Performance of various laboratory assays in the measurement of dabigatran in patients receiving therapeutic doses: a prospective study based on peak and trough plasma levelsRobert Gosselin, Emily Hawes, Stephan Moll, et al.
Hamostaseologie|July 6, 2017
Clinical pearls: Laboratory assessments of direct oral anticoagulants (DOACS)Robert C Gosselin, Robert Gosselin, Jonathan Douxfils, et al.
American Journal of Clinical Pathology|December 29, 2012
The effect of dabigatran on select specialty coagulation assaysDorothy M Adcock, Robert Gosselin, Steve Kitchen, et al.
Clinical Chemistry and Laboratory Medicine|May 4, 2018
Recent initiatives in harmonization of hemostasis practiceEmmanuel J Favaloro, Robert Gosselin, John Olson, et al.
Journal of Thrombosis and Thrombolysis|March 23, 2013
Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhageJennifer L Aron, Robert Gosselin, Stephan Moll, et al.
European Journal of Radiology|October 8, 2008
MR imaging changes in the trochanteric area of asymptomatic individuals: a potential for misdiagnosis of pain in the trochanteric regionMichel De Maeseneer, Robert Gosselin, Fillip De Ridder, et al.
Pageof 3